(Albany, US) DelveInsight has launched a new report on Stargardt Disease Epidemiology
DelveInsight’s ‘Stargardt Disease (STGD) Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Stargardt Disease (STGD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Stargardt Disease (STGD) is named after Karl Stargardt, a German ophthalmologist who first reported a case in his practice in 1901. It is also called Stargardt macular dystrophy, juvenile macular degeneration, or fundus flavimaculatus. It is a rare retinal disorder inherited in an autosomal recessive pattern. Decreased central vision due to loss of photoreceptors in the macula is the hallmark of Stargardt disease. It typically develops during childhood or adolescence, but the age of onset and rate of progression can vary. Mutations in a gene called ABCA4 are the most common cause of Stargardt disease. This gene makes a protein that normally clears away vitamin A byproducts inside rods and cones (photoreceptors). Cells that lack the ABCA4 protein accumulate clumps of lipofuscin, a fatty substance that forms yellowish flecks. As the clumps of lipofuscin increase in and around the macula, central vision becomes impaired. Eventually, these fatty deposits lead to the death of photoreceptors and vision becomes further impaired.
View Free Sample Page:- https://www.delveinsight.com/sample-request/stargardt-disease-stgd-epidemiology-forecast
Stargardt Disease Epidemiology
Stargardt disease is a form of macular degeneration, and is often called juvenile macular degeneration. Macular degeneration is when part of the retina that gives you central vision, called the macula, breaks down. In people with Stargardt disease, special light-sensing cells in the macula, called photoreceptors, die off. Central, or detailed, vision becomes blurry or has dark areas. It may also be difficult to see colors well. For most people, vision loss progresses slowly over time to 20/200 or worse.
Stargardt Disease key Facts
Stargardt Disease Report Scope
Download Free Sample Page:- https://www.delveinsight.com/sample-request/stargardt-disease-stgd-epidemiology-forecast
Table of content
1. Key Insights
2. Executive Summary of Stargardt Disease (STGD)
3. Stargardt Disease (STGD): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Why should you buy this report?
Related Reports
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/